spectacular result from a solid business.
the dividend yield is strong, which will attract those chasing income.
Printable View
Excellent result and well pleased with the larger than expected final dividend of 7 cps, a record.
Looking ahead they expect $93 - $96m which is slightly ahead of my expectations with the mid point being $94.5m.
Early calculations, I have them on a forward PE of 13.2 and a gross yield of 7.5% (assuming eps of 16 cps which is midpoint of their forecast and dividends of 11.5 cps).
Very happy holders and signed up to their dividend reinvestment plan quite some time ago. I am expecting a record high closing share price today.
Yes ticked all the boxes.
Yes thanks Jeff and the team very happy long term holder.
That's a nice divvie, happy to accept these for the foreseeable future :)
Yeah a nice day for a lockdown indeed when this 7 cents dividend jive with the 7% weighting of this stock on my portfolio.
Keep the good news coming this week :t_up:
Yes...great stock to own. One of the keys to income investing in retirement (or as one approaches retirement), is to find companies that can pay you excellent fully imputed dividends that grow over time.
HGH could easily pay 12 cps, (up from 11 cps in FY21) in fully imputed dividends in FY22 reflecting their forecast ~ 8% eps growth.
Its easy to take our imputation system for granted. The reality is not that many OECD countries have such a system.
Steady as she goes. This has been one of my better investments, it has grown to 10% of my portfolio at this point. With a forward PE of ~13.5 it is very tempting to make it 15%!
I am a happy holder too. Imputation credits certainly help to avoid double taxation of dividends. Instead of imputation credits, other OECD countries provide a personal income tax-free dividend allowance and personal investment and pension schemes with preferential tax regimes and the ability make before tax gross contributions.
Awesome result, great dividend stock to have in my portfolio. I started adding to my position from April last year until the end of the year and its become the biggest part of my portfolio now.
My only problem is if I want to reinvest or keep the cash (I'll likely reinvest).
I think the guidance is watered down a bit, but its a HGH thing they like to update. I actually prefer it this way, more upside in the future.
Muted reaction from market in terms of volume, bugger all so far, however price moved up exactly by divvy amount.